REGISTERED NUMBER: 12727107 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

CHURCH PHARMA (BILSTON) LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mohan Lal Sahni

Jaswinder Paul Sahni

REGISTERED OFFICE:

43A - 45 Church St

Bilston

United Kingdom

WV14 0AX

REGISTERED NUMBER:

12727107 (England and Wales)

ACCOUNTANTS:

Brindleys Limited

2 Wheeleys Road

Edgbaston

Birmingham

West Midlands

B15 2LD

FIXED ASSETS

Intangible assets

4

643,491

683,709

Tangible assets

5

51,426

58,572

694,917

742,281

CURRENT ASSETS

Stocks

6

87,000

75,000

Debtors

7

763,719

596,190

Cash at bank and in hand

66,565

103,259

917,284

774,449

CREDITORS

Amounts falling due within one year

8

1,284,202

1,284,266

NET CURRENT LIABILITIES

(366,918

)

(509,817

)

TOTAL ASSETS LESS CURRENT LIABILITIES

327,999

232,464

CREDITORS

Amounts falling due after more than one year

9

(92,070

)

-

PROVISIONS FOR LIABILITIES

11

(12,856

)

(14,643

)

NET ASSETS

223,073

217,821

CAPITAL AND RESERVES

Called up share capital

12

1

1

Retained earnings

13

223,072

217,820

SHAREHOLDERS' FUNDS

223,073

217,821

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 September 2025 and were signed on its behalf by:

Mohan Lal Sahni - Director

1.	STATUTORY INFORMATION

Church Pharma (Bilston) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2022, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

15% on reducing balance

Motor vehicles

-

25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 20 (2024 - 15 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2024

and 31 March 2025

804,364

AMORTISATION

At 1 April 2024

120,655

Charge for year

40,218

At 31 March 2025

160,873

NET BOOK VALUE

At 31 March 2025

643,491

At 31 March 2024

683,709

5.	TANGIBLE FIXED ASSETS

Fixtures

and

Motor

fittings

vehicles

Totals

£

£

£

COST

At 1 April 2024

93,526

1,581

95,107

Additions

2,008

-

2,008

At 31 March 2025

95,534

1,581

97,115

DEPRECIATION

At 1 April 2024

35,621

914

36,535

Charge for year

8,987

167

9,154

At 31 March 2025

44,608

1,081

45,689

NET BOOK VALUE

At 31 March 2025

50,926

500

51,426

At 31 March 2024

57,905

667

58,572

6.

STOCKS

2025

2024

£

£

Stocks

87,000

75,000

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

132,665

151,250

Amounts owed by group undertakings

472,889

417,892

Other debtors

130,000

-

VAT

19,034

19,263

Prepayments

9,131

7,785

763,719

596,190

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts (see note 10)

34,764

-

Trade creditors

224,647

206,092

Amounts owed to group undertakings

912,146

963,430

Tax

43,349

50,100

Social security and other taxes

3,141

2,791

Other creditors

58,629

50,923

Accrued expenses

7,526

10,930

1,284,202

1,284,266

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans (see note 10)

92,070

-

10.

LOANS

An analysis of the maturity of loans is given below:

2025

2024

£

£

Amounts falling due within one year or on demand:

Bank loans

34,764

-

Amounts falling due between one and two years:

Bank loans - 1-2 years

34,764

-

2025

2024

£

£

Amounts falling due between two and five years:

Bank loans - 2-5 years

57,306

-

11.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

12,856

14,643

Deferred

tax

£

Balance at 1 April 2024

14,643

Provided during year

(1,787

)

Balance at 31 March 2025

12,856

12.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

1

Ordinary A

1

1

1

13.

RESERVES

Retained

earnings

£

At 1 April 2024

217,820

Profit for the year

5,252

At 31 March 2025

223,072